跳至主要内容
临床试验/IRCT201206306907N4
IRCT201206306907N4已完成未知

The efficacy and safety of cinnarizine and sodium valproate in prophylaxis of migraine among children and adolescents aged 6 to 17: a randomized, double-blind, placebo-controlled clinical trial

Tehran University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6 years 至 17 years(—)
性别
All

入选标准

  • Patients with migraine (with or without aura), diagnosed according to the International Headache society criteria
  • Patients who had at least four migraine attacks per 4 weeks; or sever dysfunction in daily and school activities during prospective baseline phase.

排除标准

  • Chronic headache, complications of migraine or other migraine variant
  • Children and adolescents with Focal neurologic deficit
  • History of diagnosed sensitivity to each of drugs that used in the study
  • Patients who took prophylactic therapy for migraine within 8 weeks before study.
  • Headaches related to structural brain lesions

研究者

相似试验